Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,457.00    6.00 (0.41%)
Bid:
1,464.00
Ask:
1,466.00
Spread: 2.00 (0.137%)
Market Cap: £3.08b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Block listing Interim Review

4 Oct 2021 09:55

RNS Number : 9028N
Hikma Pharmaceuticals Plc
04 October 2021
 

Hikma Pharmaceuticals PLC

 

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

 

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

SOP: 792,700 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 0 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 792,700 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

LTIP: 57,502 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

LTIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

LTIP: 0 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

LTIP: 57,502 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

2009 MIP: 136,182 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

2009 MIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2009 MIP: 136,182 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2009 MIP: 0 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

2018 MIP: 1,000,000 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

2018 MIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2018 MIP: 226,506 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2018 MIP: 773,494 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

EIP: 1,239,967 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

EIP: 350,000 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

EIP: 340,434 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

EIP: 1,249,533 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

LEI: 549300BNS685UXH4JI75

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUPGCAUUPGURC
Date   Source Headline
12th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 200912:35 pmRNSTotal Voting Rights
20th Oct 200912:21 pmRNSBlocklisting Interim Review
16th Oct 200912:30 pmRNSDirector/PDMR Shareholding
1st Oct 200910:10 amRNSAdditional Listing
1st Oct 200910:04 amRNSTotal Voting Rights
27th Aug 20097:00 amRNSHalf Yearly Report
5th Aug 200911:51 amRNSTotal Voting Rights
17th Jul 20097:00 amRNSHikma signs licensing agreement
29th Jun 200911:58 amRNSDirector/PDMR Shareholding
19th May 200910:42 amRNSDirector/PDMR Shareholding
14th May 20096:12 pmRNSResult of AGM
14th May 20097:00 amRNSInterim Management Statement
12th May 20095:37 pmRNSAnnual Information Update
11th May 20092:08 pmRNSTotal Voting Rights
11th May 20091:57 pmRNSDirector/PDMR Shareholding
16th Apr 20094:00 pmRNSDirector/PDMR Shareholding
9th Apr 20093:59 pmRNSAnnual Financial Report
19th Mar 20095:02 pmRNSDirector/PDMR Shareholding
18th Mar 20094:39 pmRNSDirector/PDMR Shareholding
17th Mar 20097:00 amRNSFinal Results
26th Jan 200911:14 amRNSHolding(s) in Company
15th Jan 20093:58 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSTrading Statement
2nd Jan 200910:07 amRNSTotal Voting Rights
3rd Dec 20083:10 pmRNSTotal Voting Rights
25th Nov 20087:00 amRNSStatement re Injectables Presentation
5th Nov 20087:00 amRNSInterim Management Statement
3rd Nov 200810:40 amRNSTotal Voting Rights
22nd Oct 20089:42 amRNSBlocklisting Interim Review
17th Oct 20085:26 pmRNSDirector/PDMR Shareholding
13th Oct 20082:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20084:51 pmRNSTotal Voting Rights
15th Sep 20085:21 pmRNSDirector/PDMR Shareholding
2nd Sep 20085:30 pmRNSTotal Voting Rights
28th Aug 20087:00 amRNSInterim Results
6th Aug 20089:25 amRNSTotal Voting Rights
21st Jul 20087:00 amRNSTrading Statement
2nd Jul 200811:53 amRNSTotal Voting Rights
25th Jun 20084:31 pmRNSDirector/PDMR Shareholding
25th Jun 200811:43 amRNSHolding(s) in Company
15th May 20085:18 pmRNSResults of Annual General Mee
15th May 200811:00 amRNSAGM and IMS
15th May 20089:07 amRNSTR-1: Notifications of Major
12th May 20082:37 pmRNSAnnual Information Update
30th Apr 20083:22 pmRNSLTIP Awards
15th Apr 20082:40 pmRNSNotice of Annual Report
31st Mar 20082:43 pmRNSDirector/PDMR Shareholding
18th Mar 20087:02 amRNSPreliminary Results
4th Mar 20083:25 pmRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.